Keyphrases
Chronic Hepatitis B Patients
100%
Alanine Aminotransferase
100%
Sustained Virological Response
100%
Circulating miRs
100%
Interferon alpha Therapy
100%
MiR-22
100%
MiR-210
100%
Virological Response
100%
MicroRNA
60%
Interferon-α (IFN-α)
40%
Area under the ROC Curve
40%
Scoring Model
40%
Training Group
20%
Nucleoside Analogues
20%
Outcome Prediction
20%
Training Phase
20%
Lack of Response
20%
Prognostic Value
20%
Validation Phase
20%
Personalized Treatment
20%
Circulating microRNA
20%
Therapy Decision
20%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha Interferon
100%
Alanine Aminotransferase
100%
Chronic Hepatitis B
100%
microRNA 22
100%
microRNA 210
100%
microRNA
50%
Nucleoside Analog
16%
Side Effect
16%
Circulating microRNA
16%
Neuroscience
microRNA 210
100%
Alanine Aminotransferase
100%
Mir-22
100%
Interferon Alfa
100%
MicroRNA
50%
Nucleoside Analog
16%
Circulating microRNA
16%
Biochemistry, Genetics and Molecular Biology
Interferon
100%
Transaminase
100%
Alanine
100%
Mir-22
100%
MicroRNA
66%
Nucleoside Analog
16%
Immunology and Microbiology
Interferon Alfa
100%
Hepatitis B
100%
Alanine
100%